Results 211 to 220 of about 4,419,243 (284)

Shaping the Flow: Impact of Blade Shape on Performance and Hemocompatibility in Rotodynamic Blood Pumps

open access: yesArtificial Organs, EarlyView.
Blade shapes (leading‐edge geometry and thickness) in rotodynamic blood pumps were systematically evaluated. Thinner blades improve pump efficiency by reducing blockage effects, while neither blade thickness nor leading‐edge geometry shows clear hemocompatibility benefits. Overall, blade shape has a limited impact on hemocompatibility, indicating it is
Benjamin Torner   +7 more
wiley   +1 more source

Development of Implantable Right Ventricular Assist Device

open access: yesDevelopment of Implantable Right Ventricular Assist Device
論文(Article)
openaire   +1 more source

Global Recommendations for the Use of Diagnostic Genomic Sequencing in the Prenatal Setting on Behalf of the ESHG and ISPD

open access: yes
Prenatal Diagnosis, EarlyView.
Zandra C. Deans   +18 more
wiley   +1 more source

National Practice Patterns of VA ECMO and Left Ventricular Mechanical Unloading for Cardiogenic Shock

open access: yesArtificial Organs, EarlyView.
Consensus surrounding the management of VA ECMO and left ventricular mechanical unloading for cardiogenic shock (CS) is limited. We thus conducted a national survey of practice patterns in the treatment of CS to characterize such variability, finding large heterogeneity in CS diagnosis, VA ECMO initiation, and LVMU strategies.
Dustin M. Anderson‐Bell   +16 more
wiley   +1 more source

Geometry‐Related Technical Complications After LVAD Implantation: Impact on Device Dysfunction and Clinical Outcomes

open access: yesArtificial Organs, EarlyView.
Preventable geometric failure modes, such as outflow graft kinking and inflow malposition, frequently cause HeartMate 3 dysfunction. This study identifies these complications as key drivers of device‐related morbidity, highlighting the importance of optimized surgical positioning to ensure long‐term device performance and improved clinical outcomes ...
Ali Saad Merzah   +17 more
wiley   +1 more source

Monitoring Mitochondrial Function With High‐Resolution Respirometry During Ex‐Situ Heart Perfusion

open access: yesArtificial Organs, EarlyView.
Normothermic ESHP preserves mitochondrial respiratory function over 6 h in a porcine model (n = 6): OXPHOS capacities across NADH‐, fatty‐acid‐, and succinate‐linked pathways remain stable, with reduced cytochrome‐c control efficiency indicating improved outer‐membrane integrity. HRR provides a rapid, actionable readout for organ assessment.
Lukas Stastny   +12 more
wiley   +1 more source

Efficacy of Antimicrobial Silver‐Plated Dressings Compared to Usual Care in Preventing Left Ventricular Assist Device Driveline Infections

open access: yesArtificial Organs, EarlyView.
Integrating silver‐plated wound dressings into DLES care presents a safe and effective strategy for DLI prevention. Key findings include a 100% infection‐free rate in the Silverlon group, no NPWT and hospital readmission in the Silverlon group, and no severe DESTINE stages (3, 4) in the Silverlon group.
Barbara Veiter   +9 more
wiley   +1 more source

Experimental Extracorporeal Circulation System: A Pilot Study in Rats

open access: yesArtificial Organs, EarlyView.
A miniature extracorporeal circulation (ECC) system was developed for reproducible rodent studies. This system incorporates an integrated heat exchanger and a silicone membrane oxygenator within a double‐lumen circuit, resulting in an ultralow priming volume of < 1.5 mL.
Akira T. Kawaguchi   +7 more
wiley   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

open access: yesArtificial Organs, EarlyView.
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy